Association of midgestation paraoxonase 1 activity and pregnancies complicated by preterm birth

Objective The objective of the study was to determine whether an association exists between low paraoxonase 1 activity and dyslipidemia at midgestation and preterm birth. Study Design We conducted a case-control study of 30 women with preterm birth and 90 women with uncomplicated term deliveries. Ma...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of obstetrics and gynecology Vol. 203; no. 3; pp. 246.e1 - 246.e4
Main Authors Baker, Arthur M., MD, Haeri, Sina, MD, MHSA, Klein, Richard L., PhD, Boggess, Kim, MD
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.09.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective The objective of the study was to determine whether an association exists between low paraoxonase 1 activity and dyslipidemia at midgestation and preterm birth. Study Design We conducted a case-control study of 30 women with preterm birth and 90 women with uncomplicated term deliveries. Maternal serum collected at 15-20 weeks was used to measure lipid concentrations and paraoxonase 1 activity using 2 substrates: paraoxon and phenylacetate (arylesterase activity). Results The groups did not differ with respect to maternal demographics. Paraoxonase 1 activity (paraoxon) was significantly lower in women delivering preterm compared with controls (12.9 ± 6.1 vs 16.6 ± 7.7 dA/min; P = .02). Arylesterase activity and serum lipid concentrations were similar between women with preterm birth and controls. Conclusion Midgestation paraoxonase 1 activity is lower in women who later experience spontaneous preterm birth compared with women who have term deliveries. Prospective studies are needed to determine the significance of paraoxonase 1 in the pathogenesis of preterm birth.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2010.04.048